CDER’s Galson Says Statin Switches May Be Ready For A Second Look
This article was originally published in The Tan Sheet
Executive Summary
The time may be right for FDA to revisit statins as a possible Rx-to-OTC switch category of drugs, according to Acting CDER Director Steve Galson, MD